Clinical trials
Phase 1 Dyslipidemias trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrowhead Pharmaceuticals | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Eccogene | 1 |
| Indication Bioscience LLC | 1 |
| Silence Therapeutics plc | 1 |
| University of Sydney | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 7 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertriglyceridemia | 2 |
| Coronary Disease | 1 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Hypercholesterolemia | 1 |
| Hyperglycemia | 1 |
| Hyperlipidemias | 1 |
| Hyperlipoproteinemia Type II | 1 |
| Hyperlipoproteinemia Type V | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.